ZK-93426 – (89592-45-0)

ZK-93426 is a potent and selective benzodiazepine receptor antagonist with weak inverse agonist properties. It is a member of the beta-carboline family and exhibits a unique pharmacological profile. Unlike typical benzodiazepine antagonists, ZK-93426 does not induce convulsions and has mild anticonvulsant effects. In human studies, it has been shown to increase alertness, restlessness, and feelings of apprehension, effectively reversing the sedative effects of benzodiazepines such as lormetazepam. Additionally, ZK-93426 demonstrates nootropic properties and enhances acetylcholine release, suggesting potential cognitive benefits.

In clinical trials, ZK-93426 has been investigated for its effects on sleep patterns. When administered intravenously to healthy male volunteers, it significantly reduced slow-wave sleep and increased light sleep stages, indicating a stimulant effect. This was accompanied by an elevated number and intensity of movements during the first 90 minutes after injection. Despite these effects on sleep architecture, ZK-93426 was well-tolerated, with no significant changes observed in body temperature or hormonal levels.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/ZK-93426
https://pubchem.ncbi.nlm.nih.gov/compound/115210
https://www.medkoo.com/products/14508
https://pubmed.ncbi.nlm.nih.gov/7753965/